The FDA Clears Wave Neuroscience's MeRT System
References: prnewswire
Wave Neuroscience has achieved a significant regulatory milestone with the U.S. Food and Drug Administration's clearance of its MeRT System, marking the first personalized biomarker-guided neuromodulation technology to receive FDA clearance for the treatment of Post-Traumatic Stress Disorder. This move is said to establish a new category in precision mental healthcare.
The MeRT, or Magnetic EEG-guided Resonance Therapy, platform utilizes a patient's own brain data through AI-augmented EEG analysis to inform highly personalized treatment protocols that optimize delivery based on each individual's unique neural activity patterns. The FDA clearance of the personalized biomarker-guided neuromodulation technology differentiates it from historical one-size-fits-all approaches. The clearance was supported by a double-blinded randomized controlled multisite trial conducted in partnership with the Texas A&M Health Institute of Biosciences and Technology, which demonstrated significant and clinically meaningful reductions in PTSD symptoms.
Image Credit: Wave Neuroscience
The MeRT, or Magnetic EEG-guided Resonance Therapy, platform utilizes a patient's own brain data through AI-augmented EEG analysis to inform highly personalized treatment protocols that optimize delivery based on each individual's unique neural activity patterns. The FDA clearance of the personalized biomarker-guided neuromodulation technology differentiates it from historical one-size-fits-all approaches. The clearance was supported by a double-blinded randomized controlled multisite trial conducted in partnership with the Texas A&M Health Institute of Biosciences and Technology, which demonstrated significant and clinically meaningful reductions in PTSD symptoms.
Image Credit: Wave Neuroscience
Consumer Demand Drives Foldable and Multi-Screen Devices
Consumers are adopting foldable and multi-screen devices as they seek more versatile and pocketable screen options for enhanced mobility and functionality.
Question 1
Which of the following types of devices have you personally used in the past 12 months?
Select up to 8
Question 2
What are the main reasons you use or chose this type of device?
Select up to 3
Question 3
How likely would you be to choose a foldable or multi-screen device the next time you purchase a smartphone, tablet, or laptop?
Trend Themes
-
Precision Mental Healthcare — Biomarker-guided treatment models are reshaping psychiatric care by aligning therapies with individualized neural patterns instead of standardized protocols.
-
AI-augmented EEG Diagnostics — Advanced EEG interpretation powered by artificial intelligence creates new pathways for real-time brain mapping, patient stratification, and adaptive treatment planning.
-
Personalized Neuromodulation — Tailored stimulation therapies introduce opportunities for more targeted, measurable, and condition-specific interventions across complex neurological and psychiatric disorders.
Industry Implications
-
Digital Therapeutics — Software-enabled treatment platforms are expanding beyond behavioral support into clinically validated, data-driven interventions for regulated healthcare markets.
-
Neurotechnology — Brain-sensing and stimulation systems are advancing toward personalized therapeutic ecosystems that combine hardware, biomarkers, and adaptive analytics.
-
Behavioral Health — Objective brain-based measurement in PTSD care signals a shift toward precision diagnostics and treatment models within mental health services.
5.9
Score
Popularity
Activity
Freshness
